Contraception: X最新文献

{"title":"Missed opportunity for self-injectable contraception awareness and adoption: Insights from client exit interviews in Uganda and Nigeria","authors":"Susan Ontiri ,&nbsp;Claire Rothschild ,&nbsp;Doreen Nakimuli ,&nbsp;Oluwatosin Adeoye","doi":"10.1016/j.conx.2023.100098","DOIUrl":"10.1016/j.conx.2023.100098","url":null,"abstract":"<div><h3>Objectives</h3><p>To assess the extent to which self-injection contraceptive information and services are provided to women in Uganda and Nigeria.</p></div><div><h3>Study design</h3><p>We conducted a descriptive information cascade analysis using data from a cross-sectional exit interviews with 492 family planning clients in Uganda and 720 in Nigeria.</p></div><div><h3>Results</h3><p>More than a third of respondents in Uganda (31.2%) and Nigeria (40.5%) reported not receiving any information about the self-injection contraceptive during service provision. Only 45.6% clients who adopted self-injected DMPA-SC in Uganda and 1.7% in Nigeria were issued with additional doses to take home.</p></div><div><h3>Conclusion</h3><p>The findings suggest that there are missed opportunities to provide women with information and services on DMPA-SC self-injection.</p></div><div><h3>Implication</h3><p>A contraceptive counseling and services cascade can be a useful tool for identifying gaps in the quality and person-centeredness of family planning services, and ultimately improving the experience of clients.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100098"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/51/b0/main.PMC10495597.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10252695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"“Adoption is just not for me”: How abortion patients in Michigan and New Mexico factor adoption into their pregnancy outcome decisions","authors":"Liza Fuentes,&nbsp;Megan L. Kavanaugh,&nbsp;Lori F. Frohwirth,&nbsp;Jenna Jerman,&nbsp;Nakeisha Blades","doi":"10.1016/j.conx.2023.100090","DOIUrl":"10.1016/j.conx.2023.100090","url":null,"abstract":"<div><h3>Objectives</h3><p>In public discourses in the United States, adoption is often suggested as a less objectionable, equal substitute for abortion, despite this pregnancy outcome occurring much less frequently than the outcomes of abortion and parenting. This qualitative study explores whether and how abortion patients weighed adoption as part of their pregnancy decisions and, for those who did, identifies factors that contributed to their ultimate decision against adoption.</p></div><div><h3>Study design</h3><p>We interviewed 29 abortion patients from 6 facilities in Michigan and New Mexico in 2015. We conducted a thematic analysis using both deductive and inductive approaches to describe participants’ perspectives, preferences, and experiences regarding the consideration of adoption for their pregnancy.</p></div><div><h3>Results</h3><p>Participants’ reasons why adoption was not an appropriate option for their pregnancy were grounded in their ideas of the roles and responsibilities of parenting and fell into three themes. First, participants described continuing the pregnancy and giving birth as inseparable from the decision to parent. Second, choosing adoption would represent an irresponsible abnegation of parental duty. Third, adoption could put their child’s safety and well-being at risk.</p></div><div><h3>Conclusions</h3><p>Adoption was not an equally acceptable substitute for abortion among abortion patients. For them, adoption was a decision that represented taking on, and then abdicating, the role of parent. This made adoption a particularly unsuitable choice for their pregnancy.</p></div><div><h3>Implications</h3><p>Rhetoric suggesting that adoption is an equal alternative to abortion does not reflect the experiences, preferences, or values of how abortion patients assess what options are appropriate for their pregnancy.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100090"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/93/66/main.PMC10008919.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9129345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation","authors":"Vera Halpern ,&nbsp;Angie Wheeless ,&nbsp;Vivian Brache ,&nbsp;Anja Lendvay ,&nbsp;Leila Cochón ,&nbsp;Douglas Taylor ,&nbsp;Laneta J. Dorflinger","doi":"10.1016/j.conx.2023.100100","DOIUrl":"10.1016/j.conx.2023.100100","url":null,"abstract":"<div><h3>Objectives</h3><p>This study aimed to evaluate and compare local tolerability of investigational drug TV-46046 and reference drug Depo-subQ Provera 104, both containing medroxyprogesterone acetate (MPA) as an active ingredient.</p></div><div><h3>Study design</h3><p>We conducted a randomized, crossover, single-center study. Twenty-seven healthy women aged 25 to 47 years at low risk of pregnancy received a subcutaneous injection of each of the four study drugs (120 mg/0.3 mL of TV-46046, 60 mg/0.3 mL of diluted TV-46046, 0.3 mL of TV-46046 placebo, and 104 mg/0.65 mL of Depo-subQ 104) in different quadrants of the abdomen. We assessed local tolerability by occurrence of injection site reactions (ISRs), as well as injection site pain and overall safety for at least 9 months postinjections.</p></div><div><h3>Results</h3><p>Of a total of 108 study injections, three injections were partial due to needle blockage. We observed a total of 30 ISRs following 105 full-dose injections, including hypopigmentation (<em>n</em> = 24), bruising (<em>n</em> = 4), and atrophy/dimple (<em>n</em> = 2). Eleven cases of hypopigmentation occurred following 25 full-dose injections of undiluted TV-46046 (44.0%), six following 27 full-dose injections of diluted TV-46046 (22.2%), and seven following 26 full-dose injections of Depo-subQ 104 (26.9%). Hypopigmentations occurred on average 8 months postinjection. Injection pain was minimal and dissipated quickly after all four injections.</p></div><div><h3>Conclusions</h3><p>Subcutaneous administration of MPA in a suspension formulation is associated with the delayed onset of hypopigmentation at the site of injection. Although not statistically significant, the rate of ISRs was over 60% higher for undiluted TV-46046 compared to Depo-subQ 104. This difference bears careful monitoring in future studies of TV-46046.</p></div><div><h3>Implications</h3><p>From a safety standpoint, investigational drug TV-46046 is appropriate for further clinical testing as a 6-month contraceptive injectable. The previously underreported hypopigmentation associated with subcutaneous administration of MPA warrants further investigation and acceptability assessment among users of existing Depo-subQ 104 as well as careful monitoring of local tolerability of TV-46046 in future clinical trials.</p></div><div><h3>Trial registration</h3><p>Registered at clinicaltrials.gov no: NCT02817464</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100100"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41194039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020","authors":"Clara E. Busse ,&nbsp;Chase D. Latour ,&nbsp;Sara Z. Dejene ,&nbsp;Andrea K. Knittel ,&nbsp;Mollie E. Wood ,&nbsp;Alan C. Kinlaw ,&nbsp;Mekhala V. Dissanayake","doi":"10.1016/j.conx.2023.100101","DOIUrl":"10.1016/j.conx.2023.100101","url":null,"abstract":"<div><h3>Objectives</h3><p>Characterize new use of long-acting reversible contraceptives (LARCs), highly effective contraceptive methods, in a broad population over time.</p></div><div><h3>Study Design</h3><p>We constructed a retrospective cohort of commercially insured individuals aged 15 to 54 years from 2010 to 2020 and estimated monthly incidence of new LARC insertions.</p></div><div><h3>Results</h3><p>The monthly standardized incidence increased from 6.0 insertions per 10,000 individuals in January 2010 to 14.1 in December 2020, with a dip in insertions after March 2020. Hormonal intrauterine devices were consistently the most inserted LARC; implants were increasingly favored over time.</p></div><div><h3>Conclusions</h3><p>LARCs are increasingly popular forms of contraception among commercially insured individuals.</p></div><div><h3>Implications</h3><p>Given the increasing popularity, ensuring access to LARCs is critical.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100101"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/3c/main.PMC10562738.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41194040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of the COVID-19 pandemic on publicly supported clinics providing contraceptive services in four US states","authors":"Jennifer Mueller,&nbsp;Alicia VandeVusse,&nbsp;Samira Sackietey,&nbsp;Ava Braccia,&nbsp;Jennifer J. Frost","doi":"10.1016/j.conx.2023.100096","DOIUrl":"10.1016/j.conx.2023.100096","url":null,"abstract":"<div><h3>Objectives</h3><p>The COVID-19 pandemic has disrupted contraceptive service provision in the United States (US). We aimed to explore the impact of COVID-19 on the publicly supported family planning network at the provider level. This study adds to the literature documenting the challenges of the pandemic as well as how telehealth provision compares across timepoints.</p></div><div><h3>Study design</h3><p>We conducted a survey among sexual and reproductive health (SRH) providers at 96 publicly supported clinics in four US states asking about two timepoints—one early in the pandemic and one later in the pandemic. We used descriptive statistics to summarize the data.</p></div><div><h3>Results</h3><p>We found that almost one-third of sites reduced contraceptive services because of the pandemic, with a few temporarily stopping contraceptive services altogether. More sites stopped provision of long-acting reversible contraception (LARC), Pap tests, and Human papillomavirus (HPV) vaccinations than other methods or services. We also found that sites expanded some practices to make them more accessible to patients, such as extending existing contraceptive prescriptions without consultations for established patients and expanding telehealth visits for contraceptive counseling. In addition, sites reported high utilization of telehealth to provide contraceptive services.</p></div><div><h3>Conclusions</h3><p>Understanding how service delivery changed due to the pandemic and how telehealth can be used to provide SRH services sheds light on how these networks can best support providers and patients in the face of unprecedented crises such as the COVID-19 pandemic.</p></div><div><h3>Implications</h3><p>This study demonstrates that providers increased provision of telehealth for sexual and reproductive health care during the COVID-19 pandemic; policymakers in the US should support continued reimbursement of telehealth care as well as resources to expand telehealth infrastructure. In addition, this study highlights the need for more research on telehealth quality.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100096"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9907769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to “Evaluation of the LMUP in Ethiopia: Requirements, challenges and best practice”","authors":"Celia Karp,&nbsp;Caroline Moreau,&nbsp;Solomon Shiferaw,&nbsp;Assefa Seme,&nbsp;Mahari Yihdego,&nbsp;Linnea Zimmerman","doi":"10.1016/j.conx.2023.100099","DOIUrl":"10.1016/j.conx.2023.100099","url":null,"abstract":"","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100099"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10524074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is long‐acting reversible contraceptive method use associated with HIV testing frequency in KwaZulu‐Natal, South Africa and Lusaka, Zambia? Findings from the CUBE study","authors":"Mags Beksinska ,&nbsp;Alice F. Cartwright ,&nbsp;Jennifer Smit ,&nbsp;Margaret Kasaro ,&nbsp;Jennifer H. Tang ,&nbsp;Maria Fawzy ,&nbsp;Virginia Maphumulo ,&nbsp;Manze Chinyama ,&nbsp;Esther Chabu ,&nbsp;Rebecca Callahan","doi":"10.1016/j.conx.2023.100089","DOIUrl":"10.1016/j.conx.2023.100089","url":null,"abstract":"<div><h3>Objectives</h3><p>To assess differences in HIV testing at 6-months intervals over 24 months among intramuscular depot medroxyprogesterone acetate (DMPA-IM) injectable, levonorgestrel implant, or copper intrauterine devices (IUD) users in KwaZulu-Natal, South Africa, and Lusaka, Zambia. Testing at recommended intervals has not been previously assessed in long-acting reversible contraceptive (LARC) users (implant and IUD users) compared to those using effective but shorter-acting methods (such as DMPA-IM) in sub-Saharan Africa.</p></div><div><h3>Study design</h3><p>As part of the longitudinal contraceptive use beyond ECHO (CUBE) study, we measured HIV testing over 24 months. Participants were considered continuous users of DMPA-IM, levonorgestrel implant, or copper IUD if they used the same method across all months of their study participation, or not continuous users of their baseline CUBE method if they switched or discontinued their method. We used multivariable logistic regression models with generalized estimating equations and robust standard errors, stratified by country, to assess differences in HIV testing.</p></div><div><h3>Results</h3><p>Among the 498 participants, HIV testing rates were higher in Zambia for all methods compared to South Africa. In bivariate analyses, continuous implant or IUD users (the LARC users) were significantly less likely to report having received HIV testing at the 6-months and 24-months surveys, compared to continuous DMPA-IM users. In adjusted longitudinal models, continuous IUD users (adjusted odds ratio: 0.42, 95% CI: 0.24, 0.74), continuous implant users (adjusted odds ratio: 0.23, 95% CI: 0.12, 0.42) in South Africa had significantly lower odds of HIV testing compared to continuous DMPA-IM users. There were no significant differences in Zambia in the adjusted models.</p></div><div><h3>Conclusion</h3><p>LARC use may reduce opportunities for HIV testing and users should be counseled on regular HIV testing and the option of HIV self-testing.</p></div><div><h3>Implications</h3><p>Due to infrequent clinical contacts which may lead to lower rates of HIV testing at recommended intervals, LARC users should be provided opportunities to test for HIV at home or when seeking other health services.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100089"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a3/1e/main.PMC9883203.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9208339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Female condom color and scent preference in Durban, South Africa","authors":"Mags Beksinska ,&nbsp;Jenni Smit ,&nbsp;Amanda Mona ,&nbsp;Virginia Maphumulo ,&nbsp;Nonhlanhla Mphili ,&nbsp;Nontsikelelo Manzini-Matebula ,&nbsp;Thato Chidarikire","doi":"10.1016/j.conx.2023.100095","DOIUrl":"10.1016/j.conx.2023.100095","url":null,"abstract":"<div><h3>Objectives</h3><p>To assess preferences for female condom (FC) colors and scents.</p></div><div><h3>Study design</h3><p>Women aged 18–40 years were randomized to one of three FCs (FC2, Cupid1, Cupid2) two of which offered a choice of color and scent (red/strawberry, purple/vanilla, natural/unscented). Women could choose any variety within condom types while participating in an FC contraceptive efficacy study in South Africa.</p></div><div><h3>Results</h3><p>One hundred and thirty-three women were allocated to each FC type. Strawberry was the most popular variety for both FC2 and Cupid1 (60.9%, 78.3% respectively). Some women chose more than one variety but few chose the natural.</p></div><div><h3>Conclusions</h3><p>Data support a clear preference for colored and scented FCs.</p></div><div><h3>Implications</h3><p>These data can inform FC programme managers to predict demand for different varieties of FC and can adjust supply of FCs accordingly.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100095"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/27/b5/main.PMC10404533.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9968168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Do users of long-acting reversible contraceptives receive the same counseling content as other modern method users? A cross-sectional, multi-country analysis of women's experiences with the Method Information Index in six sub-Saharan African countries","authors":"Brooke W. Bullington ,&nbsp;Katherine Tumlinson ,&nbsp;Celia Karp ,&nbsp;Leigh Senderowicz ,&nbsp;Linnea Zimmerman ,&nbsp;Pierre Z. Akilimali ,&nbsp;Musa Sani Zakirai ,&nbsp;Funmilola M. OlaOlorun ,&nbsp;Simon P.S. Kibira ,&nbsp;Frederick Edward Makumbi ,&nbsp;Solomon Shiferaw ,&nbsp;PMA Principal Investigators Group","doi":"10.1016/j.conx.2022.100088","DOIUrl":"10.1016/j.conx.2022.100088","url":null,"abstract":"<div><h3>Objective</h3><p>There has been a growing focus on informed choice in contraceptive research. Because removal of long-acting reversible contraception (LARC), including implants and IUDs, requires a trained provider, ensuring informed choice in the adoption of these methods is imperative. We sought to understand whether information received during contraceptive counseling differed among women using LARC and those using other modern methods of contraception.</p></div><div><h3>Study Design</h3><p>We used cross-sectional data from Burkina Faso, Côte d'Ivoire, the Democratic Republic of Congo (DRC), Kenya, Nigeria, and Uganda collected in 2019–2020 by the Performance Monitoring for Action project. We included 7969 reproductive-aged women who reported use of modern contraception. Our outcome of interest, information received during contraceptive counseling, was measured using a binary indicator of whether respondents answered “yes” to all 4 questions that make up the Method Information Index Plus (MII+). We used modified Poisson models to estimate the prevalence ratio between method type (LARC vs. other modern methods) and the MII+, controlling for individual- and facility-level covariates.</p></div><div><h3>Results</h3><p>Reported receipt of the full MII+ during contraceptive counseling ranged from 21% in the DRC to 51% in Kenya. In all countries, a higher proportion of LARC users received the MII+ compared to other modern method users. A greater proportion of LARC users answered “yes” to all questions that make up the MII+ at the time of counseling compared to other modern method users in DRC, Kenya, Nigeria, and Uganda. There was no significant difference in the prevalence of reporting the full MII+ between users of LARC and other modern methods in Burkina Faso (Adjusted prevalence ratio (aPR): 1.16; 95% confidence interval (CI): 0.91, 1.48) and Côte d'Ivoire (aPR: 1.13; 95% CI: 0.87, 1.45).</p></div><div><h3>Conclusion</h3><p>Information received during contraceptive counseling was limited for all modern contraceptive users. LARC users had significantly higher prevalence of receiving the MII+ compared to other modern method users in the DRC, Kenya, and Uganda. Family planning programs should ensure that all women receive complete, unbiased contraceptive counseling.</p></div><div><h3>Implications</h3><p>Across 6 sub-Saharan African countries, a substantial proportion reproductive-aged women using contraception did not report receiving comprehensive counseling when they received their method. Women using long-acting reversible contraception received more information compared to women using other modern methods in the DRC, Kenya, Nigeria, and Uganda after controlling for individual- and facility-level factors.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"4 ","pages":"Article 100088"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10324424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Women's experiences with person-centered family planning care: Differences by sociodemographic characteristics","authors":"Kate Welti,&nbsp;Jennifer Manlove,&nbsp;Jane Finocharo,&nbsp;Bianca Faccio,&nbsp;Lisa Kim","doi":"10.1016/j.conx.2022.100081","DOIUrl":"10.1016/j.conx.2022.100081","url":null,"abstract":"<div><h3>Objective</h3><p>Person-centered contraceptive care is associated with positive reproductive health outcomes. Our objective was to analyze patients’ ratings on the newly developed Person-Centered Contraceptive Counseling scale (PCCC) to provide distributions for a nationally representative population and to assess differences by sociodemographic characteristics.</p></div><div><h3>Study design</h3><p>Using data from 2017 to 2019 National Survey of Family Growth (NSFG), we analyzed ratings across the four PCCC items among 2242 women who received contraceptive counseling in the past year. Items measured patients’ reports of how providers respected them, let them describe their contraceptive preferences, took their preferences seriously, and adequately informed them about their options. We studied each PCCC item individually as well as the combined scale, distinguishing between ratings of “excellent” versus lower ratings. Bivariate and multivariate logistic regression models assessed how patients’ characteristics (age, race/ethnicity and English proficiency, sexual orientation, income, and parity) and provider type were associated with the likelihood of experiencing person-centered care.</p></div><div><h3>Results</h3><p>The majority of women (59%–69%) reported that their family planning provider was “excellent” across the four PCCC items and just over half (51%) reported “excellent” on all items. In multivariate analyses, having a lower income, Black race, non-heterosexual identity, and Hispanic ethnicity combined with low English proficiency were associated with lower PCCC ratings.</p></div><div><h3>Conclusions</h3><p>In a nationally representative sample, the PCCC captured variation in women's experiences with person-centered family planning care by sociodemographic characteristics. Findings highlight the need for contraceptive counseling that centers on clients’ preferences and experiences, particularly for patients who belong to groups experiencing health inequities.</p></div><div><h3>Implications</h3><p>Person-centered care is a key component of high-quality family planning services. This analysis highlights sociodemographic disparities in person-centered care by analyzing PCCC ratings. Findings show the value of this new health care performance measure and affirm the need for family planning care that centers individuals' preferences and lived experiences.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"4 ","pages":"Article 100081"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/52/80/main.PMC9372601.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40696424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}